Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001420720-25-000012
Filing Date
2025-02-10
Accepted
2025-02-10 16:15:31
Documents
102
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q ibio-20241231x10q.htm   iXBRL 10-Q 2000250
2 EX-31.1 ibio-20241231xex31d1.htm EX-31.1 15618
3 EX-31.2 ibio-20241231xex31d2.htm EX-31.2 18643
4 EX-32.1 ibio-20241231xex32d1.htm EX-32.1 10497
5 EX-32.2 ibio-20241231xex32d2.htm EX-32.2 6613
6 GRAPHIC ibio-20241231x10q001.jpg GRAPHIC 52853
7 GRAPHIC ibio-20241231x10q002.jpg GRAPHIC 95398
8 GRAPHIC ibio-20241231x10q003.jpg GRAPHIC 70535
  Complete submission text file 0001420720-25-000012.txt   11554188

Data Files

Seq Description Document Type Size
9 EX-101.SCH ibio-20241231.xsd EX-101.SCH 74472
10 EX-101.CAL ibio-20241231_cal.xml EX-101.CAL 55322
11 EX-101.DEF ibio-20241231_def.xml EX-101.DEF 460290
12 EX-101.LAB ibio-20241231_lab.xml EX-101.LAB 568137
13 EX-101.PRE ibio-20241231_pre.xml EX-101.PRE 661452
105 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20241231x10q_htm.xml XML 1838867
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 25605927
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)